Cell-in-cell: an emerging player in COVID-19 and immune disorders
Qiang Sun, Wei Chen
Abstract
Cell-in-cell is a unique phenomenon mostly documented in human cancer tissues. A recent study demonstrated that cell-in-cell might promote lymphopenia by internalizing and killing immune cells in COVID-19, which implicates cell-in-cell as an emerging player in a broader spectrum of pathological processes, such as immune dysregulation.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)Immune system2019-20 coronavirus outbreakCellSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyMedicineBiologyImmunologyGeneticsDiseaseInternal medicineOutbreakInfectious disease (medical specialty)Phagocytosis and Immune RegulationImmune responses and vaccinationsCOVID-19 Clinical Research Studies